Eye Catching Stocks: AbbVie Inc. (NYSE:ABBV), DepoMed Inc. (NASDAQ:DEPO), Misonix Inc. (NASDAQ:MSON), Bebe Stores, Inc. (NASDAQ:BEBE)

AbbVie (NASDAQ:ABBV) had its target price boosted by Credit Suisse from $60.00 to $63.00 in a report issued on Wednesday. They currently have an outperform rating on the stock.AbbVie Inc. (NYSE:ABBV) shares moved down -0.21% in last trading session and ended the day at $55.75. ABBV Gross Margin is 76.40% and its return on assets is 14.50%. AbbVie Inc. (NYSE:ABBV) quarterly performance is 3.89%.

DepoMed Inc. (NASDAQ:DEPO) announced that it will be presenting at the Morgan Stanley 2014 Global Healthcare Conference in New York City. On 26 August, DepoMed Inc. (NASDAQ:DEPO) shares increased 0.60% and was closed at $15.10. DEPO EPS growth in last 5 year was 34.10%. DepoMed Inc. (NASDAQ:DEPO) year to date (YTD) performance is 42.72%.

Misonix Inc. (NASDAQ:MSON) ended the last trading day at $6.80. Company weekly volatility is calculated as 1.18%and price to cash ratio as 8.84. Misonix Inc. (NASDAQ:MSON) showed a weekly performance of 3.66%.

bebe stores, inc. (NASDAQ:BEBE) today announced that it will host a conference call on Thursday, September 4, 2014 at 1:30 P.M. (PT) / 4:30 P.M. (ET) to discuss its fourth quarter and fiscal 2014 year end results. Bebe Stores, Inc. (NASDAQ:BEBE) shares increased 5.32% in last trading session and ended the day on $2.97. BEBE Gross Margin is 32.00% and its return on assets is -21.30%. Bebe Stores, Inc. (NASDAQ:BEBE) quarterly performance is -26.30%.